Beta results prompt early access to AI drug design software
University of Cambridge spin-out DeepMirror, software developers for the discovery of novel therapeutic drugs, has launched an Early Access Programme after a successful closed beta programme during which chemists were invited to test the software over several months. Click to read more...
United Kingdom United States Max Jakobs Early Access Programme University Of Cambridge Boston Consulting Group
Source: labmate-online.com